64304500CRD2001: A Phase 2b Randomized Double-blind Placebo-controlled Parallel-group Multicenter Protocol to Evaluate the Safety and Efficacy of JNJ-64304500 in Subjects with Moderately to Severely Active Crohn?s Disease
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.